- Telehealth Visits
- Insurance plan information
Ingrid Juliana Block-Kurbisch, MD
She | Her | HersMaternal and Fetal Medicine- Telehealth Visits
- Insurance plan information
Ingrid Juliana Block-Kurbisch, MD
She | Her | HersMaternal and Fetal Medicine- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Ingrid Juliana Block-Kurbisch is an endocrinologist who specializes in treating endocrine disorders that complicate pregnancy. She collaborates with a team of maternal-fetal medicine specialists and endocrinology fellows to optimize care for patients with high-risk pregnancies.
Block-Kurbisch earned her medical degree at the University of Vienna in Austria. She completed a residency in internal medicine at California Pacific Medical Center and a fellowship in diabetes and metabolism at UCSF.
Outside of work, Block-Kurbisch enjoys spending time with her family. She also loves hiking, running, gardening, reading, cooking and baking. She is a passionate fan of classical music and ballet.
Education & training
Board certification
- Endocrinology Diabetes & Metab, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Fellowship
- University of CA at San Francisco School of Med
Residency
- Internal Medicine, California Pacific Medical Center GME
Internship
- Internal Medicine, California Pacific Medical Center GME
Degree
- MD, University of Wien School of Medicine
My expertise
Specialties
Clinical Trials query: q=health_gateway_id_ss%3A%28%22308%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22308%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.